Cannabidiol for Adjuvant Treatment of Seizures Associated with Lennox–Gastaut Syndrome and Dravet Syndrome: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

Review Group ◽

Vedolizumab for Treating Moderately to Severely Active Crohn’s Disease After Prior Therapy: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

PharmacoEconomics ◽

10.1007/s40273-016-0436-6 ◽

2016 ◽

Vol 34 (12) ◽

pp. 1241-1253 ◽

Cited By ~ 5

Author(s):

Rachid Rafia ◽

Alison Scope ◽

Sue Harnan ◽

John W. Stevens ◽

Matt Stevenson ◽

...

Keyword(s):

Crohn’S Disease ◽

Crohn's Disease ◽

Evidence Review Group ◽

Technology Appraisal ◽

Review Group ◽

Prior Therapy ◽

Sipuleucel-T for the Treatment of Metastatic Hormone-Relapsed Prostate Cancer: A NICE Single Technology Appraisal; An Evidence Review Group Perspective

PharmacoEconomics ◽

10.1007/s40273-015-0296-5 ◽

2015 ◽

Vol 33 (11) ◽

pp. 1187-1194 ◽

Cited By ~ 11

Author(s):

Emma L. Simpson ◽

Sarah Davis ◽

Praveen Thokala ◽

Penny R. Breeze ◽

Peter Bryden ◽

...

Keyword(s):

Prostate Cancer ◽

Evidence Review Group ◽

Technology Appraisal ◽

Review Group ◽

Fulvestrant for Untreated Hormone-Receptor Positive Locally Advanced or Metastatic Breast Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

PharmacoEconomics ◽

10.1007/s40273-018-0725-3 ◽

2018 ◽

Vol 37 (6) ◽

pp. 753-762

Author(s):

Joanna Picot ◽

Neelam Kalita ◽

Wendy Gaisford ◽

Petra Harris ◽

Oluchukwu Onyimadu ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Locally Advanced ◽

Metastatic Breast ◽

Evidence Review Group ◽

Technology Appraisal ◽

Review Group ◽

Hormone Receptor Positive ◽

Arsenic Trioxide for Treating Acute Promyelocytic Leukaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

PharmacoEconomics ◽

10.1007/s40273-018-0738-y ◽

2018 ◽

Vol 37 (7) ◽

pp. 887-894 ◽

Cited By ~ 2

Author(s):

Bram L. T. Ramaekers ◽

Rob Riemsma ◽

Sabine Grimm ◽

Debra Fayter ◽

Sohan Deshpande ◽

...

Keyword(s):

Arsenic Trioxide ◽

Acute Promyelocytic Leukaemia ◽

Evidence Review Group ◽

Promyelocytic Leukaemia ◽

Technology Appraisal ◽

Review Group ◽

Correction to: Ceritinib for Untreated Anaplastic Lymphoma Kinase-Positive Advanced Non-Small-Cell Lung: An Evidence Review Group Evaluation of a NICE Single Technology Appraisal

PharmacoEconomics ◽

10.1007/s40273-018-0743-1 ◽

2018 ◽

Vol 37 (5) ◽

pp. 739-739

Author(s):

Lindsay Claxton ◽

Joanne O’Connor ◽

Nerys Woolacott ◽

Kath Wright ◽

Robert Hodgson

Keyword(s):

Anaplastic Lymphoma Kinase ◽

Evidence Review Group ◽

Small Cell ◽

Technology Appraisal ◽

Small Cell Lung ◽

Review Group ◽

Anaplastic Lymphoma ◽

Group Evaluation ◽

Mogamulizumab for Previously Treated Mycosis Fungoides and Sézary Syndrome: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

PharmacoEconomics ◽

10.1007/s40273-021-01098-3 ◽

2021 ◽

Author(s):

Sabine E. Grimm ◽

Willem Witlox ◽

Robert Wolff ◽

Annette Chalker ◽

Mickael Hiligsmann ◽

...

Keyword(s):

Mycosis Fungoides ◽

Evidence Review Group ◽

Sézary Syndrome ◽

Sezary Syndrome ◽

Technology Appraisal ◽

Review Group ◽

Previously Treated ◽

Nalmefene for Reducing Alcohol Consumption in People with Alcohol Dependence: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

PharmacoEconomics ◽

10.1007/s40273-015-0272-0 ◽

2015 ◽

Vol 33 (8) ◽

pp. 833-847 ◽

Cited By ~ 19

Author(s):

Matt Stevenson ◽

Abdullah Pandor ◽

John W. Stevens ◽

Andrew Rawdin ◽

Peter Rice ◽

...

Keyword(s):

Alcohol Consumption ◽

Alcohol Dependence ◽

Evidence Review Group ◽

Technology Appraisal ◽

Review Group ◽

Ixekizumab for Treating Moderate-to-Severe Plaque Psoriasis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

PharmacoEconomics ◽

10.1007/s40273-018-0629-2 ◽

2018 ◽

Vol 36 (8) ◽

pp. 917-927 ◽

Cited By ~ 3

Author(s):

Bram L. T. Ramaekers ◽

Robert F. Wolff ◽

Xavier Pouwels ◽

Marije Oosterhoff ◽

Anoukh Van Giessen ◽

...

Keyword(s):

Plaque Psoriasis ◽

Evidence Review Group ◽

Technology Appraisal ◽

Review Group ◽

Severe Plaque Psoriasis ◽

Ponatinib for Treating Chronic Myeloid Leukaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

PharmacoEconomics ◽

10.1007/s40273-018-0627-4 ◽

2018 ◽

Vol 36 (8) ◽

pp. 903-915 ◽

Cited By ~ 2

Author(s):

Abdullah Pandor ◽

Matt Stevenson ◽

John Stevens ◽

Marrissa Martyn-St James ◽

Jean Hamilton ◽

...

Keyword(s):

Chronic Myeloid Leukaemia ◽

Myeloid Leukaemia ◽

Evidence Review Group ◽

Technology Appraisal ◽

Review Group ◽

Durvalumab for the Treatment of Locally Advanced, Unresectable, Stage III Non-Small Cell Lung Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

PharmacoEconomics ◽

10.1007/s40273-019-00870-w ◽

2019 ◽

Vol 38 (4) ◽

pp. 317-324 ◽

Cited By ~ 2

Author(s):

Willem J. A. Witlox ◽

Antoinette D. I. van Asselt ◽

Robert Wolff ◽

Nigel Armstrong ◽

Gill Worthy ◽

...

Keyword(s):

Lung Cancer ◽

Locally Advanced ◽

Evidence Review Group ◽

Small Cell ◽

Technology Appraisal ◽

Small Cell Lung ◽

Review Group ◽

Unresectable Stage ◽